Applied Microbiology,
Год журнала:
2023,
Номер
3(4), С. 1204 - 1213
Опубликована: Окт. 17, 2023
Factors
associated
with
COVID-19
presentation
in
children
asthma
are
poorly
defined.
Our
study
aimed
to
assess
the
clinical
course
of
asthma,
particular
attention
possible
risk
factors
for
severe
disease
and
long-term
sequelae
this
group
patients.
We
assessed
occurrence
SARS-CoV-2
infection
six
months
before
their
regular
outpatient
visit
clinic.
Characteristics
patients
presenting
signs
upper
(URTI)
or
lower
respiratory
tract
(LRTI)
were
compared.
focused
on
previously
severity.
Twenty-seven
percent
(57/210)
reported
exposure
infection.
In
symptomatic
group,
36%
(15/42)
symptoms
LRTI
64%
(27/42)
URTI.
Poorer
control
was
observed
compared
URTI
(80%
vs.
7%,
p
<
0.001).
addition,
poorer
had
a
higher
multiple
logistic
regression
analysis.
not
ICS
use
However,
better
(p
=
0.026).
found
no
PFT
deterioration
post-COVID-19
either
results
suggest
good
treatment
adherence
prior
outcomes
asthma.
Pediatric Allergy Immunology and Pulmonology,
Год журнала:
2022,
Номер
35(4), С. 174 - 178
Опубликована: Дек. 1, 2022
Background:
Studies
suggest
that
children
with
asthma
experienced
improved
symptom
control
and
less
frequent
inpatient
admission
during
the
COVID-19
(coronavirus
disease
2019)
pandemic.
The
characteristics
of
hospitalized
remain
well
defined.
Methods:
This
retrospective
cohort
study
compared
patients
admitted
for
pandemic
year
prior
at
a
children's
hospital
in
Bronx,
New
York.
Results:
In
before
pandemic,
667
were
asthma,
177
following
year.
Children
older
(7.8
versus
7.0
years,
P
=
0.04),
more
likely
underweight
(P
<
0.01),
to
have
public
insurance
0.02).
Additionally,
required
intensive
care
0.03)
magnesium
sulfate
0.05)
frequently.
Despite
this,
length
stay
remained
similar.
Conclusion:
While
utilization
decreased
sicker
on
presentation.
cause
this
is
multifactorial
requires
further
study.
Pediatric Pulmonology,
Год журнала:
2023,
Номер
58(10), С. 2757 - 2760
Опубликована: Июль 4, 2023
Abstract
Pediatric
asthma
care
was
significantly
impacted
by
the
Coronavirus
Disease
(COVID‐19)
pandemic,
with
significant
decline
in
health
utilization
noted
early
pandemic.
We
compared
Emergency
Department
(ED)
rates
and
prescription
fill
of
controller
quick
relief
medications
between
March
December
2020
versus
2021
a
county‐specific
pediatric
Medicaid
population
to
evaluate
for
changes
later
Our
data
showed
an
increase
ED
46.7%
(
p
‐.0371)
second
year
There
no
change
fills
reliever
‐.1309)
during
this
time
increased
but
there
medication
‐.0039).
This
suggests
potential
explanation
resurgence
because
decreased
use
frame
that
also
saw
viral
positivity
rates.
The
poor
adherence
despite
visits
new
interventions
may
be
needed
assist
patients
adherence.
Applied Microbiology,
Год журнала:
2023,
Номер
3(4), С. 1204 - 1213
Опубликована: Окт. 17, 2023
Factors
associated
with
COVID-19
presentation
in
children
asthma
are
poorly
defined.
Our
study
aimed
to
assess
the
clinical
course
of
asthma,
particular
attention
possible
risk
factors
for
severe
disease
and
long-term
sequelae
this
group
patients.
We
assessed
occurrence
SARS-CoV-2
infection
six
months
before
their
regular
outpatient
visit
clinic.
Characteristics
patients
presenting
signs
upper
(URTI)
or
lower
respiratory
tract
(LRTI)
were
compared.
focused
on
previously
severity.
Twenty-seven
percent
(57/210)
reported
exposure
infection.
In
symptomatic
group,
36%
(15/42)
symptoms
LRTI
64%
(27/42)
URTI.
Poorer
control
was
observed
compared
URTI
(80%
vs.
7%,
p
<
0.001).
addition,
poorer
had
a
higher
multiple
logistic
regression
analysis.
not
ICS
use
However,
better
(p
=
0.026).
found
no
PFT
deterioration
post-COVID-19
either
results
suggest
good
treatment
adherence
prior
outcomes
asthma.
